24 Followers on Owler

SK Capital

SK Capital Partners operates as a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors. Read more

Barry Siadat's photo - Managing Director of SK Capital

Managing Director

Barry Siadat

CEO Approval Rating

88/100

Founded:

2007

Status:

Investment CompanyIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of SK Capital?

SK Capital Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Valentus Specialty Chemicals, Inc.

May 2021

Source »
undisclosed
Valentus is a New Jersey-based chemical company that provides wood floor coatings and related products for sectors such as residential and commercial.
Canlak, Inc.

May 2021

Source »
undisclosed
Canlak is a Canada-based chemical company that develops and provides waterbase topcoats, polymer house covering, and related products for residential and commercial sectors.

-

Blow-Fill-Seal Sterile Contract Development and Manufacturing Business, Catalent Pharma Solutions, LLC

Jan 2021

Source »
undisclosed
-
Lacerta Group, Inc.

Jan 2021

Source »
undisclosed
Lacerta is a manufacturer and distributor of PET packaging products for food and beverage sector.
Ipackchem Group SAS

Dec 2020

Source »
undisclosed
Ipackchem is a manufacturer and distributor of blow-molded plastic bottles and containers for food processing, agrochemical and packaging sectors.

These are all the companies that SK Capital has acquired. SK Capital has acquired 16 companies and its latest acquisition was Valentus Specialty Chemicals, Inc. in May 2021. Valentus is a New Jersey-based chemical company that provides wood floor coatings and related products for sectors such as residential and commercial.

SK Capital Funding History

Since SK Capital was founded in 2007, it has participated in 3 rounds of funding. In total SK Capital has raised $1.4B. SK Capital's last funding round was on Nov 2019 for a total of $400.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Investment Fund
Nov 2019
$400M
-
Investment Fund
Feb 2019
--
-
Investment Fund
Dec 2014
$1B

Since SK Capital was founded in 2007, it has participated in 3 rounds of funding. In total SK Capital has raised $1.4B. SK Capital's last funding round was on Nov 2019 for a total of $400.0M

SK Capital Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Archroma is a manufacturer of color and specialty chemicals for emulsion, textile and paper industries.
-
Aug 16, 2017
Equity
Oct 01, 2013
Halo Pharmaceutical is a manufacturer of pharmaceutical products including drugs, ointment and generic medicines.
-
Jan 05, 2015
Growth
Jul 01, 2018

These are all the companies that SK Capital has invested in. SK Capital has invested 16 companies and its latest investment was Valentus Specialty Chemicals, Inc. in May 2021. Valentus is a New Jersey-based chemical company that provides wood floor coatings and related products for sectors such as residential and commercial.

SK Capital News

April 15, 2021Chemical Week

SK Capital in talks to acquire Clariant's pigments business

Other bidders have dropped out, negotiations on the value of the proposed acquisition are ongoing.... See more »
April 13, 2021Market Report Company

SK Capital closed acquisition of Ipackchem

April 7, 2021NS Packaging

SK Capital wraps up acquisition of packaging firm Ipackchem

The post SK Capital wraps up acquisition of packaging firm Ipackchem appeared first on NS Packaging.... See more »
March 31, 2021Contract Pharma

SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions

Renames the business to Woodstock Sterile Solutions.... See more »
February 16, 2021Chemical Week

Former Versalis CEO joins SK Capital

Ferrari was CEO of Versalis, a subsidiary of energy giant Eni, for nine years.... See more »
February 16, 2021privateequitywire

SK Capital Partners appoints senior director

SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and phar... See more »
January 22, 2021Global Legal Chronicle

SK Capital Partners' Catalent's Blow-Fill-Seal Sterile CDMO Business

Kirkland & Ellis LLP acted as legal counsel to SK Capital, while Paul, Weiss, Rifkind, Wharton & Garr... See more »

SK Capital Press Releases

August 1, 2018Business Wire India

Ascend Performance Materials Acquires Britannia Techno Polymer

Business Wire IndiaAscend Performance Materials, the largest global fully integrated producer of nylo... See more »
June 25, 2018Newswire

Ascend Performance Materials Announces Price Increase for Intermediate Materials

Ascend Performance Materials announced today a price increase for its intermediate materials.... See more »
February 27, 2018Business Wire

Ascend to Lift Force Majeure on HMD Production

HOUSTON--(BUSINESS WIRE)--Ascend to lift force majeure on HMD production... See more »
October 30, 2017Business Wire

Ascend to Increase Capacity of Nylon 6,6 Building Blocks, Polymers by 10 to 15 Percent

HOUSTON--(BUSINESS WIRE)--Ascend Performance Materials, the world's largest fully integrated producer... See more »
August 16, 2017Business Wire

Ascend Completes $6.2 Million Expansion Project, Adds 27 Jobs in Greenwood

HOUSTON--(BUSINESS WIRE)--Ascend Performance Materials, a global leader in the production of specialt... See more »
August 10, 2017skcapitalpartners

SK Capital Announces Agreement to Acquire Perrigo Company plc's Active Pharmaceutical Ingredients Business

SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceutica... See more »
July 12, 2017Blackbird

Ascend Steps up Production of Bulk High-Concentration Hexamine Liquid

HOUSTON-(BUSINESS WIRE)-Ascend Performance Materials, a global leader in the production of specialty ... See more »

Social Media

SK Capital Headquarters

400 Park Ave Suite 820

New York, New York10022

212-826-2700

Driving Directions »

Trending Companies

SK Capital Summary

ABOUT

Overview

SK Capital Partners operates as a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors. SK Capital was founded in 2007. SK Capital's headquarters is located in New York, New York, USA 10022. It ...

CEO

SK Capital's Managing Director, Barry Siadat, currently has an approval rating of 88%. SK Capital's primary competitors are

Frequently Asked Questions about SK Capital

  1. When was SK Capital founded?

    SK Capital was founded in 2007
  2. Who is SK Capital's CEO?

    SK Capital's CEO is Barry Siadat
  3. How much revenue does SK Capital generate?

    SK Capital generates $8.5B in revenue
  4. How much funding does SK Capital have?

    SK Capital has historically raised $1.4B in funding
  1. Where is SK Capital's headquarters?

    SK Capital's headquarters is in New York New York, USA
  2. How many employees does SK Capital have?

    SK Capital has 850 employees
  3. Who has SK Capital invested in?

    SK Capital's has invested in companies such as Archroma, Halo Pharmaceutical